These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 17410334)
1. Association of telomerase gene hTERT polymorphism and malignant gliomas. Carpentier C; Lejeune J; Gros F; Everhard S; Marie Y; Kaloshi G; Laigle-Donadey F; Hoang-Xuan K; Delattre JY; Sanson M J Neurooncol; 2007 Sep; 84(3):249-53. PubMed ID: 17410334 [TBL] [Abstract][Full Text] [Related]
2. Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. Wang L; Wei Q; Wang LE; Aldape KD; Cao Y; Okcu MF; Hess KR; El-Zein R; Gilbert MR; Woo SY; Prabhu SS; Fuller GN; Bondy ML J Clin Oncol; 2006 Apr; 24(10):1627-32. PubMed ID: 16575014 [TBL] [Abstract][Full Text] [Related]
3. Association between hTERT polymorphisms and the risk of breast cancer in a sample of Southeast Iranian population. Hashemi M; Amininia S; Ebrahimi M; Hashemi SM; Taheri M; Ghavami S BMC Res Notes; 2014 Dec; 7():895. PubMed ID: 25491902 [TBL] [Abstract][Full Text] [Related]
4. MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome. Andersson U; Osterman P; Sjöström S; Johansen C; Henriksson R; Brännström T; Broholm H; Christensen HC; Ahlbom A; Auvinen A; Feychting M; Lönn S; Kiuru A; Swerdlow A; Schoemaker M; Roos G; Malmer B Int J Cancer; 2009 Aug; 125(4):968-72. PubMed ID: 19405125 [TBL] [Abstract][Full Text] [Related]
5. Association of strong risk of hTERT gene polymorphic variants to malignant glioma and its prognostic implications with respect to different histological types and survival of glioma cases. Pandith AA; Wani ZA; Qasim I; Afroze D; Manzoor U; Amin I; Baba SM; Koul A; Anwar I; Mohammad F; Bhat AR; Shah P J Gene Med; 2020 Nov; 22(11):e3260. PubMed ID: 32783258 [TBL] [Abstract][Full Text] [Related]
6. Telomerase activity and hTERT mRNA expression in glial tumors. Boldrini L; Pistolesi S; Gisfredi S; Ursino S; Ali G; Pieracci N; Basolo F; Parenti G; Fontanini G Int J Oncol; 2006 Jun; 28(6):1555-60. PubMed ID: 16685456 [TBL] [Abstract][Full Text] [Related]
7. HTERT MNS16A polymorphism in breast cancer: a case-control study. Zagouri F; Sergentanis TN; Gazouli M; Tsigginou A; Dimitrakakis C; Eleutherakis-Papaiakovou E; Papaspyrou I; Chrysikos D; Theodoropoulos G; Zografos GC; Antsaklis A; Dimopoulos AM; Papadimitriou CA Mol Biol Rep; 2012 Dec; 39(12):10859-63. PubMed ID: 23065203 [TBL] [Abstract][Full Text] [Related]
8. Association between human telomerase reverse transcriptase (hTERT) MNS16A polymorphism and risk of breast cancer. Salehi-Reyhani SM; Saadat M Mol Biol Rep; 2024 Oct; 51(1):1055. PubMed ID: 39412736 [TBL] [Abstract][Full Text] [Related]
9. Association of Telomerase Reverse Transcriptase Promoter Mutations with the Prognosis of Glioma Patients: a Meta-Analysis. Wang X; Li X; Xu F; Zhang Y; Liu H; Tao Y Mol Neurobiol; 2016 May; 53(4):2726-32. PubMed ID: 26351078 [TBL] [Abstract][Full Text] [Related]
10. Association of MNS16A VNTR and hTERT rs2736098: G>A polymorphisms with susceptibility to diffuse large B-cell lymphoma. Essa ES; Alagizy HA Tumori; 2018 Jun; 104(3):165-171. PubMed ID: 28967095 [TBL] [Abstract][Full Text] [Related]
11. Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis. Spiegl-Kreinecker S; Lötsch D; Ghanim B; Pirker C; Mohr T; Laaber M; Weis S; Olschowski A; Webersinke G; Pichler J; Berger W Neuro Oncol; 2015 Sep; 17(9):1231-40. PubMed ID: 25681309 [TBL] [Abstract][Full Text] [Related]
12. TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas. Gao K; Li G; Qu Y; Wang M; Cui B; Ji M; Shi B; Hou P Oncotarget; 2016 Feb; 7(8):8712-25. PubMed ID: 26556853 [TBL] [Abstract][Full Text] [Related]
13. MNS16A tandem repeats minisatellite of human telomerase gene: a risk factor for colorectal cancer. Hofer P; Baierl A; Feik E; Führlinger G; Leeb G; Mach K; Holzmann K; Micksche M; Gsur A Carcinogenesis; 2011 Jun; 32(6):866-71. PubMed ID: 21422235 [TBL] [Abstract][Full Text] [Related]
14. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas. Lima-Ramos V; Pacheco-Figueiredo L; Costa S; Pardal F; Silva A; Amorim J; Lopes JM; Reis RM Cancer Genet Cytogenet; 2008 Jan; 180(1):14-9. PubMed ID: 18068527 [TBL] [Abstract][Full Text] [Related]
15. MNS16A VNTR polymorphism of human telomerase gene: Elucidation of a gender specific potential allele associated with type 2 diabetes in Bangladeshi population. Huda N; Yasmin T; Nabi AHMN J Diabetes Complications; 2021 Oct; 35(10):108018. PubMed ID: 34404572 [TBL] [Abstract][Full Text] [Related]
16. High CHI3L1 expression is associated with glioma patient survival. Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858 [TBL] [Abstract][Full Text] [Related]
17. Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker? Gandhi P; Khare R; Garg N J Neurooncol; 2017 Nov; 135(2):255-261. PubMed ID: 28756592 [TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism. Batista R; Cruvinel-Carloni A; Vinagre J; Peixoto J; Catarino TA; Campanella NC; Menezes W; Becker AP; de Almeida GC; Matsushita MM; Clara C; Neder L; Viana-Pereira M; Honavar M; Castro L; Lopes JM; Carvalho B; Vaz RM; Máximo V; Soares P; Sobrinho-Simões M; Reis RM; Lima J Int J Cancer; 2016 Jul; 139(2):414-23. PubMed ID: 26914704 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma. Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767 [TBL] [Abstract][Full Text] [Related]